Comparative evaluation of antioxidant, cytoprotective, and anti-arthritic activities of pomegranate peel powder and coarse powdered date seeds: implications for functional nutrition Authors: Madyha H Mahmoud, Abdulrahman A Alsayegh, Nahla Kambal, Asrar Alsaeedi, Boshra M Mozaffar, Eman Merghani A Mohammed, Ashwag H Alwadani, Halah Abdulrahman Hafiz Published: 2026 ABSTRACT Highlights•Pomegranate peel powder (PPP) showed significantly stronger antioxidant activity than coarse powdered date seeds across all assays.•PPP provided superior cytoprotective effects through erythrocyte membrane stabilization and protection against oxidative DNA damage.•Anti-arthritic potential of PPP was confirmed by marked inhibition of protein denaturation and protease activity.•The biological efficacy of PPP is attributed to synergistic multi-target interactions of its polyphenolic constituents.•Agro-waste-derived PPP represents a promising functional ingredient for nutraceutical and clinical nutrition applications.Keywords: Agro-waste valorization, Pomegranate peel, Clinical nutrition, Functional foods, Coarse powdered, Date seeds, Antioxidant activity, Cytoprotection Introduction Agro-industrial byproducts are increasingly recognized as sustainable sources of bioactive compounds with significant potential in functional foods. Among these, pomegranate peel and date seeds represent high-volume residues generated during fruit processing, yet they are often underutilized despite being rich in polyphenols, flavonoids, and other phytochemicals with well-documented antioxidant and anti-inflammatory properties.1 Oxidative stress plays a central role in the pathogenesis of various chronic diseases through the overproduction of reactive oxygen species (ROS), which can induce cellular damage, lipid peroxidation, and DNA fragmentation. Recent studies have highlighted the mechanistic involvement of oxidative stress in disease progression, including its association with ferroptosis and cellular dysfunction, further emphasizing the need for natural antioxidant sources capable of mitigating oxidative damage.2 Complicated phytochemical matrices discovered in whole plant materials may exert beneficial, numerous biological effects, providing them more advantageous for functional meals and therapeutic nutrition compared to single-target synthetic pharmaceuticals.3 Transforming these byproducts into functional ingredients that add value is in line with the principles of a circular economy and sustainable food systems.4 The peel of the pomegranate fruit (Punica granatum L.) makes up 40–50% of the fruit's weight and is known to be a concentrated source of polyphenols, such as ellagitannins, phenolic acids, flavonoids, carotenoids, vitamins, dietary fibers, and antioxidants. This phenolic-rich bioresource can be used in an eco-friendly way, and people often use it as animal feed or dump it in landfills. Finding alternative uses of waste generated from pomegranate peels could prove beneficial for both the economy and the environment,5 the integration of pomegranate peel-based supplements into food systems such as bakery, dairy, beverage and meat products enhances their microbial stability as well as shelf life and antioxidant capacity; thus, improving their nutritional value and functional significance.6 The pomegranate peel polyphenols are not only superior in technology but also exhibit significant antioxidant, anti-inflammatory, cytoprotective, and acetylcholinesterase inhibitory activity that are relevant to health and nutrition. The date palm (Phoenix dactylifera L.), a crop predominantly grown in arid and semi-arid regions, also generates substantial quantities of underutilised by-products. Coarse Powdered Date Seeds are among the significant by-products, constituting about 6–15% of the weight of fruit. The chemical composition of coarse powdered date seeds indicates that they can be a good source of dietary fibre, phenolic compounds tocopherols, carotenoids, fatty acids, and minerals.7 The consumption of dates and its derivatives may modulate glucose metabolism, lipid profile, oxidative stress and the inflammatory status may have a preventive and remediatory effect on metabolic disorders like diabetes, cardiovascular diseases, obesity, and liver damage affected due to undesirable metabolism.8 Extracts derived from date seeds possess antioxidant, anti-inflammatory, and metabolism-supporting properties as revealed in past studies, making them suitable candidates for functional food applications. Nonetheless, their phenolic diversity is mostly lower than that of pomegranate peel.9, 10 Oxidative imbalance highlights the importance of dietary antioxidants and anti-inflammatory compounds in disease prevention and management by exacerbating insulin resistance, impaired glucose metabolism, neurodegeneration, and inflammation-mediated joint degradation.11 This article explores how functional foods generated from agro-waste, abundant in polyphenols, may provide supplementary dietary approaches to reduce oxidative stress, promote cellular integrity, and control inflammatory pathways. Despite the increasing interest in plant-derived bioactive compounds as functional food ingredients, most studies have focused on individual plant sources rather than conducting direct comparative evaluations between different agro-industrial byproducts.12 This represents a significant research gap, particularly in understanding the relative biological efficacy of commonly available waste materials such as pomegranate peel and date seeds. Pomegranate peel powder (PPP) is known to be rich in polyphenols, flavonoids, and tannins, which contribute to its strong antioxidant. In contrast, coarse powdered date seeds (CPDS), although also rich in phenolic compounds, have been less extensively explored in terms of their comparative biological performance. Previous studies have highlighted that plant-derived bioactive compounds, including phenolics and flavonoids, play a crucial role in antioxidant defense, enzyme inhibition, and protection against oxidative stress-related disorders.13, 14 However, a direct comparative assessment between PPP and CPDS across multiple biological targets, including antioxidant, cytoprotective, anti-arthritic, and enzyme inhibitory activities, remains limited. Furthermore, the relationship between phytochemical composition and multi-target biological activity has not been fully elucidated. Therefore, the present study aims to comparatively evaluate the in vitro antioxidant, cytoprotective, acetylcholinesterase inhibitory, and anti-arthritic activities of PPP and CPDS. We hypothesize that PPP will exhibit superior bioactivity due to its higher phenolic content and more complex phytochemical profile. The findings of this study are expected to provide a scientific basis for the valorization of agro-waste materials as functional ingredients in food and nutraceutical applications. Materials and methods Prepartion of plant materials Pomegranate peel powder (PPP) Pomegranate peels (Punica granatum L.) and date seeds (Phoenix dactylifera L.) were collected from a local market in Egypt during the same season to minimize variability. For pomegranate, the edible arils were manually removed, and the peels were thoroughly washed with distilled water to eliminate surface contaminants.15 Date seeds were separated from the pulp, washed with tap water followed by distilled water, and cleaned to remove any residual flesh.16 Both materials were initially air-dried under shade at ambient temperature for approximately 10 days to prevent photodegradation of bioactive compounds, followed by oven drying at 40–45°C for 48 h until constant weight was achieved. The dried samples were then ground using an electric grinder (pomegranate peel) and a hammer mill (date seeds) to obtain fine powders, which were sieved through a standard mesh to ensure uniform particle size (<500 µm). The resulting powders were stored in airtight containers under dry conditions at room temperature until further extraction.15, 17 Preparation of ethanolic extracts The extraction of bioactive compounds from pomegranate peel powder (PPP) and coarse powdered date seeds (CPDS) was performed using 70% (v/v) ethanol as solvent, following a Tahir modified protocol.18 Briefly, 10 g of each powdered sample was macerated with 100 mL of ethanol (solid-to-solvent ratio 1:10, w/v) in amber glass containers at room temperature for 72 h under continuous agitation to enhance solvent penetration and extraction efficiency.19 After extraction, the mixtures were filtered through Whatman No. 1 filter paper, and the filtrates were concentrated under reduced pressure using a rotary evaporator at 45°C and 63 rpm to obtain solvent-free extracts. The dried extracts were weighed to determine extraction yield and stored in airtight containers at − 20°C until further analysis.20 In vitro biological activities Antioxidant activity Total antioxidant capacity was determined using the phosphomolybdenum method. The reaction mixture contained 0.3 mL of extract with 3 mL of reagent solution (0.6 M sulfuric acid, 28 mM sodium phosphate, and 4 mM ammonium molybdate). The mixture was incubated at 95°C for 90 min, cooled to room temperature, and absorbance was measured at 695 nm using a UV–Vis spectrophotometer. Results were expressed as mg gallic acid equivalents (GAE)/g extract.21 The reducing power was determined by mixing 1 mL of extract with 2.5 mL of phosphate buffer (0.2 M, pH 6.6) and 2.5 mL of potassium ferricyanide (1%, w/v). The mixture was incubated at 50°C for 20 min, followed by addition of 2.5 mL trichloroacetic acid (10%, w/v). After centrifugation at 3000 rpm for 10 min, 2.5 mL of the supernatant was mixed with 2.5 mL distilled water and 0.5 mL ferric chloride (0.1%,w/v). Absorbance was measured at 700 nm.22 ascorbic acid was used as standard drug. Free radical scavenging activity The free radical scavenging activity was assessed by previously stated protocol of Rahman23 along with Alcolea.24 The DPPH assay was performed using a 0.1 mM DPPH solution in methanol. A volume of 1 mL of extract at different concentrations was mixed with 1 mL of DPPH solution and incubated in the dark for 30 min at room temperature. Absorbance was measured at 517 nm. The ABTS radical cation (ABTS•+) was generated by reacting 7 mM ABTS with 2.45 mM potassium persulfate and allowing the mixture to stand in the dark for 16 h. The solution was diluted to an absorbance of (0.70 ± 0.02) at 734 nm. Then, 1 mL of ABTS solution was mixed with 1 mL of extract, incubated for 6 min, and absorbance was recorded at 734 nm. Ascorbic acid was used as a positive control standard for both assays. plots of inhibition percentage against respective extract concentration yielded median inhibitory concentration (IC50) values. Anti-Hemolytic activity The anti-hemolytic activity was assessed using the AAPH-induced erythrocyte hemolysis test described by Elizondo-Luévano,25 Fresh human blood was obtained from a certified diagnostic laboratory and collected in EDTA tubes. Erythrocytes were separated by centrifugation at 3000 rpm for 10 min and washed three times with phosphate-buffered saline (PBS, pH 7.4). A 2% erythrocyte suspension was prepared and incubated with AAPH (150 mM) in the presence or absence of extracts (7.81–1000 µg/mL) at 37°C for 3 h. After incubation, samples were centrifuged (3000 rpm, 10 min), and absorbance of the supernatant was measured at 570 nm. IC50 values were established as the extract concentration necessary to inhibit 50% of hemolysis. Anti-hemolytic activity was expressed as relative percentage membrane stabilization, calculated based on absorbance differences between treated and control samples. Values may exceed 100% due to enhanced protective effects compared to baseline hemolysis conditions. Anti-hemolytic activity (%) was calculated using the following equation: DNA protective activity Genomic DNA from human blood was extracted using the phenol–chloroform extraction method.26 The concentration of isolated DNA was adjusted to 2.0 mg/mL. Oxidative DNA damage was induced using AAPH (40 mM). Briefly, DNA solution was mixed with AAPH and different concentrations of extracts dissolved in DMSO in a final volume of 2 mL. The reaction mixtures were incubated at 37°C in a water bath to initiate oxidative damage.27 Following incubation, oxidative degradation was assessed using the thiobarbituric acid reactive substances (TBARS) method. Trichloroacetic acid (3%) and thiobarbituric acid (TBA) reagent were added, and samples were heated in a boiling water bath for 15 min. After cooling, n-butanol was added for extraction, and absorbance was measured at 535 nm.28 For qualitative analysis, DNA samples were electrophoresed on 1% agarose gel stained with ethidium bromide (1 µg/mL), run at 90 V for 2 h, and visualized under UV illumination using a gel documentation system.29 Ascorbic acid was used as the positive control. Anti-Alzheimer activity Acetylcholinesterase (AChE) inhibitory activity was measured using Ellman’s colorimetric procedure.30 Spectrophotometric monitoring of the reaction was used to express the inhibition capacity in relation to the standard medication donepezil. The reaction mixture contained 0.5 mL phosphate buffer (0.1 M, pH 8.0), 0.1 mL extract, 0.1 mL AChE enzyme solution, and 0.1 mL DTNB (5,5′-dithiobis-(2-nitrobenzoic acid), 0.5 mM) as chromogenic reagent. After pre-incubation at 25°C for 15 min, 0.1 mL acetylthiocholine iodide (ATCI, 1 mM) was added as substrate. Absorbance was measured at 412 nm. Donepezil was used as the positive reference standard. BChE inhibitory activity was assessed using the same procedure with butyrylthiocholine iodide as the substrate. Donepezil was used as a reference standard. IC50 values were calculated from inhibition curves. Anti-Arthritic activity Anti-Arthritic activity was assessed through protein denaturation and proteinase inhibition assays as per the methods referencing Das and Oyedapo.31, 32 The reference drug was a diclofenac sodium. (a) protein denaturation Assay: The reaction mixture contained 1% bovine serum albumin (BSA) and extract. The mixture was incubated at 37°C for 20 min followed by heating at 70°C for 5 min. After cooling, absorbance was measured at 660 nm. (b) proteinase inhibition Assay: The reaction mixture contained 0.06 mg trypsin, 20 mM Tris-HCl buffer (pH 7.4), and extract. After incubation at 37°C for 5 min, 0.8% casein was added and further incubated for 20 min. The reaction was terminated with 70% perchloric acid and centrifuged at 3000 rpm for 10 min. Absorbance was measured at 210 nm. Diclofenac sodium was used as a reference standard for both assays Statistical analysis All experiments were performed in triplicate (n = 3 technical replicates) to ensure reproducibility of the measurements. The extracts used in this study were prepared from homogenized bulk samples of pomegranate peel and date seeds, representing a single biological source for each material. Results were expressed as mean ± standard deviation (SD). Statistical analysis was performed using GraphPad Prism (version 8.0, San Diego, USA). One-way analysis of variance (ANOVA) followed by Tukey’s post hoc test was used to determine significant differences between groups. A p-value < 0.05 was considered statistically significant. Different superscript letters (a–c) indicate statistically significant differences between groups (p < 0.05). Ethical statement Human blood samples used for erythrocyte and DNA assays were obtained from a certified diagnostic laboratory following standard biosafety and ethical guidelines. No direct human subject recruitment was involved, and all procedures complied with institutional ethical standards. Results Antioxidant and free radical scavenging activities The antioxidant potential of PPP and CPDS was evaluated through total antioxidant capacity (TAC), iron-reducing power (IRP), and multiple radical scavenging assays including DPPH, ABTS, and nitric oxide (NO) (Table 1, Fig. 1). PPP exhibited significantly higher antioxidant activity compared to CPDS across all tested assays (p < 0.05). The TAC of PPP reached (84.68 ± 0.75 mg GAE/g), which was substantially higher than CPDS (29.71 ± 0.26 mg GAE/g) and approached that of the standard ascorbic acid. In radical scavenging assays, PPP demonstrated markedly lower IC50 values than CPDS, indicating superior antioxidant efficiency. Specifically, the IC50 values for PPP were (6.73 ± 0.14 µg/mL, DPPH), (5.42 ± 0.10 µg/mL, ABTS), and (7.96 ± 0.09 µg/mL, NO), compared to (19.18 ± 0.40 µg/mL, 13.76 ± 0.25 µg/mL, and 26.72 ± 0.35 µg/mL) for CPDS, respectively. PPP exhibited significantly lower IC50 values compared to CPDS across all evaluated assays, indicating higher biological potency; however, both extracts showed weaker activity than standard compounds such as ascorbic acid (IC50 = 4.66 µg/mL for DPPH), highlighting that while PPP is a promising natural source of bioactive compounds, its efficacy remains lower than pure reference standards. These findings confirm that PPP possesses a significantly higher capacity to neutralize reactive oxygen and nitrogen species, likely due to its richer phenolic composition. Table 1In vitro antioxidant and free radical scavenging activities of pomegranate peel powder (PPP) and Coarse Powdered Date Seeds (CPDS)represented by the inhibition percentages (%) at equal concentrations (250 µg/mL) and the median inhibitory concentrations (IC50, µg/mL) compared to ascorbic acid as standard Data are presented as mean ± SD. (n = 3). Different superscript letters within the same column indicate significant differences at p < 0.05.Antioxidant ActivityScavenging ActivityTAC(mg GAE/g)IRP(µg/mL)DPPHABTSNOInhib.(%)IC50(µg/mL)Inhib.(%)IC50(µg/mL)Inhib.(%)IC50(µg/mL)Coarse Powdered Date Seeds29.71 ± 0.26b19.96 ± 0.26c18.66 ± 0.25c19.18 ± 0.40c22.41 ± 0.25c13.76 ± 0.25c14.66 ± 0.25c26.72 ± 0.35cPomegranate Peel Powder84.68 ± 0.75 a56.90 ± 0.75b53.17 ± 0.70b6.73 ± 0.14b56.92 ± 0.70b5.42 ± 0.10b49.17 ± 0.70b7.96 ± 0.09bAscorbic Acid1.89 ± 0.43c82.14 ± 0.43 a77 ± 0.40 a4.66 ± 0.05 a80.52 ± 0.40 a3.83 ± 0.02 a72.77 ± 0.40 a5.38 ± 0.03 a In vitro antioxidant and free radical scavenging activities of pomegranate peel powder (PPP) and Coarse Powdered Date Seeds (CPDS)represented by the inhibition percentages (%) at equal concentrations (250 µg/mL) and the median inhibitory concentrations (IC50, µg/mL) compared to ascorbic acid as standard Data are presented as mean ± SD. (n = 3). Different superscript letters within the same column indicate significant differences at p < 0.05. In vitro free radical scavenging activities of pomegranate peel powder (PPP) and coarse powdered date seeds (CPDS), expressed as median inhibitory concentrations (IC50, µg/mL), compared with ascorbic acid as the reference standard. Data are presented as mean ± SD (n = 3). Different letters (a–c) indicate statistically significant differences between groups (p < 0.05) using one-way ANOVA followed by Tukey’s post hoc test. Anti-hemolytic and DNA protective effects The anti-hemolytic activity of PPP and CPDS was assessed based on erythrocyte membrane stabilization (Table 2, Fig. 2). PPP demonstrated significantly stronger membrane protective activity compared to CPDS, as reflected by a lower IC50 value (155.14 ± 1.58 µg/mL) relative to CPDS (287.02 ± 2.93 µg/mL) (p < 0.05). However, both extracts were less potent than the standard quercetin (IC50 = 113.95 ± 0.70 µg/mL). PPP also exhibited higher membrane stabilization activity (180.46 ± 0.75%) compared to CPDS (97.55 ± 0.41%), indicating superior protection against oxidative hemolysis. These results indicate that PPP has a higher cytoprotective potential, which may be attributed to its enhanced antioxidant activity and ability to prevent oxidative damage to erythrocyte membranes. Regarding DNA protection, oxidative damage was quantitatively evaluated using the TBARS spectrophotometric method, which provides a reliable and widely accepted measure of oxidative degradation through the formation of thiobarbituric acid reactive substances (absorbance at 535 nm). PPP exhibited significantly greater protection against AAPH-induced oxidative DNA damage compared to CPDS (p < 0.05), as indicated by reduced TBARS formation in PPP-treated samples. This reduction reflects the ability of PPP to inhibit oxidative degradation processes, likely through its enhanced radical scavenging capacity and metal chelation properties, which suppress the chain reactions responsible for DNA strand oxidation. The superior DNA-protective activity of PPP is therefore closely linked to its overall antioxidant profile, consistent with the higher TAC and radical scavenging efficiency observed across the antioxidant assays. Ascorbic acid was used as the positive control. Table 2In vitro anti-hemolytic activity of pomegranate peel powder (PPP), Coarse Powdered Date Seeds (CPDS), and reference compounds, expressed as Membrane Stabilization (%) at an equal concentration (250 µg/mL) and median inhibitory concentrations (IC50, µg/mL). Data are presented as mean ± SD (n = 3). Different superscript letters within the same column indicate significant differences at p < 0.05.Anti-hemolytic ActivityMembrane Stabilization Activity (%)IC50 (µg/mL)Coarse Powdered Date Seeds97.55 ± 0.41c287.02 ± 2.93cPomegranate Peel Powder180.46 ± 0.75b155.14 ± 1.58bQuercetin245.70 ± 2.41 a113.95 ± 0.70 aAll experiments were performed in triplicate and expressed as mean ± SD. In vitro anti-hemolytic activity of pomegranate peel powder (PPP), Coarse Powdered Date Seeds (CPDS), and reference compounds, expressed as Membrane Stabilization (%) at an equal concentration (250 µg/mL) and median inhibitory concentrations (IC50, µg/mL). Data are presented as mean ± SD (n = 3). Different superscript letters within the same column indicate significant differences at p < 0.05. All experiments were performed in triplicate and expressed as mean ± SD. In vitro DNA protective activity of pomegranate peel powder (PPP) and coarse powdered date seeds (CPDS) against AAPH-induced oxidative DNA damage, evaluated using the TBARS assay. Results are expressed relative to ascorbic acid as the positive control at 250 µg/mL. Data are presented as mean ± SD (n = 3). Acetylcholinesterase and butyrylcholinesterase inhibitory activity Table 3 presents the inhibitory activity of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) for PPP and CPDS. Both extracts demonstrated moderate inhibitory efficacy against acetylcholinesterase and butyrylcholinesterase. PPP exhibited marginally enhanced inhibition with IC50 values of (10.94 ± 0.20 µg/mL, AChE) and (12.92 ± 0.19 µg/mL, BChE) in contrast to CPDS (IC50: 11.32 ± 0.21 µg/mL and 13.37 ± 0.20 µg/mL, respectively). Both extracts had markedly reduced activity compared to the standard donepezil, which displayed IC50 values of 4.30 ± 0.02 µg/mL (AChE) and 5.08 ± 0.08 µg/mL (BChE) (p < 0.05) (Fig. 3). The minor discrepancies between PPP and CPDS indicate similar cholinesterase inhibitory capacity. This activity may be ascribed to bioactive phytochemicals, including polyphenols, flavonoids, and tannins, which are recognized for their interaction with the active sites of cholinesterase enzymes, thereby inhibiting their activity. The marginally increased inhibition noted in PPP may correlate with its elevated phenolic content and intricate phytochemical composition, enhancing enzyme binding and inhibitory efficacy. Table 3In vitro acetylcholinesterase iand butyrcholinesterase inhibitory activated of pomegranate peel powder (PPP), Coarse Powdered Date Seeds (CPDS), and reference compounds, expressed as inhibition percentages (%) at an equal concentration (250 µg/mL) and median inhibitory concentrations (IC50, µg/mL). Data are presented as mean ± SD (n = 3). Different superscript letters within the same column indicate significant differences at p < 0.05.Anti-Alzheimer ActivityAChEBChEInhib.(%)IC50(µg/mL)Inhib.(%)IC50(µg/mL)Coarse Powdered Date Seeds33.29 ± 0.37b11.32 ± 0.21b28.45 ± 0.32b13.37 ± 0.20bPomegranate Peel Powder34.45 ± 0.38b10.94 ± 0.20b29.45 ± 0.33b12.92 ± 0.19bSTDDonepezil87.66 ± 0.44 a4.30 ± 0.02 a74.92 ± 0.38 a5.08 ± 0.08aAll experiments were performed in triplicate and expressed as mean ± SD. In vitro acetylcholinesterase iand butyrcholinesterase inhibitory activated of pomegranate peel powder (PPP), Coarse Powdered Date Seeds (CPDS), and reference compounds, expressed as inhibition percentages (%) at an equal concentration (250 µg/mL) and median inhibitory concentrations (IC50, µg/mL). Data are presented as mean ± SD (n = 3). Different superscript letters within the same column indicate significant differences at p < 0.05. All experiments were performed in triplicate and expressed as mean ± SD. In vitro acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and anti-arthritic activities of pomegranate peel powder (PPP) and coarse powdered date seeds (CPDS), expressed as inhibition percentages (%) at 250 µg/mL and median inhibitory concentrations (IC50, µg/mL), compared with standard reference compounds. Data are presented as mean ± SD (n = 3). Different letters (a–c) indicate statistically significant differences between groups (p < 0.05) using one-way ANOVA followed by Tukey’s post hoc test. Anti-arthritic activity The anti-arthritic potential of PPP and CPDS was evaluated using protein denaturation and proteinase inhibition assays (Table 4, Fig. 3). PPP exhibited significantly higher inhibition of protein denaturation (44.73 ± 0.50%) compared to CPDS (35.78 ± 0.40%) (p < 0.05). Similarly, PPP showed stronger proteinase inhibitory activity, with a lower IC50 value (11.58 ± 0.22 µg/mL) compared to CPDS (14.76 ± 0.29 µg/mL). Despite these promising results, both extracts showed lower activity than the standard diclofenac sodium (73.42 ± 0.37% inhibition; IC50 = 6.85 ± 0.05 µg/mL). The observed anti-arthritic activity may be attributed to the ability of bioactive compounds, particularly polyphenols and flavonoids, to stabilize protein structures. These compounds can interact with proteins through hydrogen bonding and hydrophobic interactions, thereby preventing thermal denaturation and preserving protein integrity under stress conditions. This mechanism is widely recognized as a key pathway underlying anti-inflammatory effects in vitro. Table 4In vitro anti-arthritic activity of pomegranate peel powder (PPP), Coarse Powdered Date Seeds (CPDS), and reference compounds, expressed as inhibition percentages (%) at an equal concentration (250 µg/mL) and median inhibitory concentrations (IC50, µg/mL). Data are presented as mean ± SD (n = 3). Different superscript letters within the same column indicate significant differences at p < 0.05. Different superscript letters within the same column indicate significant differences at p < 0.05.Anti-arthritic ActivityProtein DenaturationProteinaseInhib.(%)Inhib.(%)IC50(µg/mL)Coarse Powdered Date Seeds35.78 ± 0.40c32.63 ± 0.40c14.76 ± 0.29cPomegranate Peel Powder44.73 ± 0.50b41.58 ± 0.50b11.58 ± 0.22bSTDDiclofenac Sodium73.42 ± 0.37a70.27 ± 0.37a6.85 ± 0.05aAll experiments were performed in triplicate and expressed as mean ± SD. In vitro anti-arthritic activity of pomegranate peel powder (PPP), Coarse Powdered Date Seeds (CPDS), and reference compounds, expressed as inhibition percentages (%) at an equal concentration (250 µg/mL) and median inhibitory concentrations (IC50, µg/mL). Data are presented as mean ± SD (n = 3). Different superscript letters within the same column indicate significant differences at p < 0.05. Different superscript letters within the same column indicate significant differences at p < 0.05. All experiments were performed in triplicate and expressed as mean ± SD. Overall, PPP consistently demonstrated superior biological activity compared to CPDS across all evaluated assays, as evidenced by lower IC50 values and higher inhibition percentages (Fig. 4). This enhanced activity may be associated with its higher phenolic content and more complex phytochemical composition. To further support this observation, a comparative analysis of IC50 values across all assays was performed (Fig. 4), providing an integrated evaluation of the biological efficacy of both extracts. Comparative median inhibitory concentrations (IC50, µg/mL) of pomegranate peel powder (PPP) and coarse powdered date seeds (CPDS) across the evaluated in vitro biological assays. Lower IC50 values indicate stronger biological activity. Data are presented as mean ± SD (n = 3). Discussion Antioxidant and free radical scavenging activity The superior antioxidant performance of pomegranate peel powder (PPP) compared to coarse powdered date seeds (CPDS) can be primarily attributed to differences in their phytochemical composition. PPP exhibited significantly lower IC50 values across DPPH, ABTS, and nitric oxide scavenging assays, indicating a stronger capacity to neutralize reactive oxygen and nitrogen species. This enhanced activity reflects a greater electron-donating ability and redox-modulating potential, which are key determinants of antioxidant efficacy.33 At a fixed concentration (250 µg/mL), PPP demonstrated inhibition percentages ranging from approximately 49% to 56% across the tested radical systems, whereas CPDS exhibited only weak to moderate activity. In general, lower IC50 values are associated with stronger antioxidant potential and greater biological relevance in protecting cells from oxidative damage. The enhanced activity of PPP is most likely related to its higher content of polyphenolic compounds, including ellagitannins, punicalagins, gallic acid, and various flavonoids. These compounds are well known for their ability to neutralize free radicals through hydrogen atom transfer or electron donation mechanisms.34 In addition, they can chelate transition metals such as Fe2+ and Cu2+, thereby limiting the formation of highly reactive hydroxyl radicals via Fenton-type reactions. Such mechanisms have been widely reported in recent studies as key contributors to the antioxidant and cytoprotective properties of plant-derived compounds.35 It is also worth noting that the different biological activities observed in this study including anti-hemolytic, enzyme inhibitory, and anti-arthritic effects may be interconnected through a shared mechanism involving the modulation of oxidative stress. Polyphenols and flavonoids can contribute to membrane stabilization, enzyme regulation, and the protection of biomolecules such as proteins and DNA from oxidative injury. Similar relationships between antioxidant capacity and multi-target biological effects have been highlighted in recent reports, supporting the multifunctional nature of these phytochemicals.36 In contrast, CPDS exhibited comparatively moderate activity, which may be explained by its lower total phenolic content and less diverse phytochemical profile. Although date seeds are recognized as a source of bioactive compounds, their antioxidant efficiency is generally lower than that of pomegranate peel, as reported in previous studies. The present findings are therefore consistent with existing literature while providing a direct comparative evaluation of these two agro-industrial byproducts under identical experimental conditions.37 The observed differences in biological activity are further supported by reported total phenolic content values, where pomegranate peel typically ranges from 4800 to 6100 mg GAE/100 g, compared to 3100 to 4430 mg GAE/100 g in date seeds. Although phytochemical profiling was not performed in the present study, the biological trends observed are in agreement with these reported values. Variations between studies may arise from differences in extraction methods, geographical origin, and experimental conditions.38, 39 Overall, these findings highlight PPP as a more potent source of natural antioxidants with multi-target biological activity. However, the results should be interpreted within the context of in vitro assays, and further studies involving detailed phytochemical characterization and in vivo validation are recommended to confirm these effects. Erythrocyte membrane stabilization and DNA protective effects The results of the present study demonstrate that pomegranate peel powder (PPP) possesses a strong ability to protect erythrocytes against oxidative hemolysis, indicating a pronounced membrane-stabilizing effect. This observation is consistent with previous reports on pomegranate peel extracts, where both aqueous and ethanolic fractions exhibited significant protection of red blood cell membranes without inducing hemolysis, even at relatively high concentrations (up to 800 µg/mL). This protective effect is mainly attributed to the presence of phenolic acids such as gallic acid, caffeic acid, and syringic acid, which are known to inhibit lipid peroxidation and stabilize the phospholipid bilayer of erythrocyte membranes. By preserving membrane integrity, these compounds reduce susceptibility to oxidative damage and prevent membrane rupture under stress conditions.39 In comparison, CPDS showed moderate anti-hemolytic activity, in agreement with previous studies reporting higher IC50 values for date seed extracts in hemolysis assays (≈480 µg/mL). Although date seeds contain phenolic compounds such as ferulic and gallic acids that contribute to membrane protection, their lower abundance and diversity may account for the reduced protective effect observed in this study. The DNA protective effect of PPP further supports its cytoprotective potential, as it demonstrated comparable activity to ascorbic acid. This effect has been widely associated with the high polyphenolic content of pomegranate peel, which can effectively scavenge peroxyl radicals, chelate transition metals, and inhibit oxidative chain reactions40. Importantly, the anti-hemolytic and DNA-protective effects appear to be mechanistically interconnected. Polyphenolic compounds can interact with lipid bilayers to enhance membrane stability, while simultaneously neutralizing reactive oxygen species responsible for DNA strand breaks. This dual action provides integrated protection at both the cellular and molecular levels. The stronger performance of PPP in both assays is therefore likely related to its higher content of bioactive compounds such as gallic acid, caffeic acid, and ellagic acid, which have been previously reported to exhibit both membrane-stabilizing and DNA-protective properties. These findings highlight the role of PPP as a multifunctional natural agent capable of mitigating oxidative damage through complementary biological mechanisms.41 Neuroprotective activity The cholinesterase inhibitory activity observed for both extracts indicates a moderate neuroprotective potential, with pomegranate peel powder (PPP) showing slightly higher inhibition of both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) compared to coarse powdered date seeds (CPDS). However, both extracts remained considerably less potent than the standard drug donepezil, which exhibited markedly lower IC50 values (p < 0.05). These findings suggest that, while PPP and CPDS possess measurable enzyme inhibitory activity, their effects are relatively mild in comparison to clinically used cholinesterase inhibitors.42 The cholinesterase inhibitory activity observed for both extracts indicates a moderate neuroprotective potential, with pomegranate peel powder (PPP) showing slightly higher inhibition of both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) compared to coarse powdered date seeds (CPDS). However, both extracts remained considerably less potent than the standard drug donepezil, which exhibited markedly lower IC50 values (p < 0.05). These findings suggest that, while PPP and CPDS possess measurable enzyme inhibitory activity, their effects are relatively mild in comparison to clinically used cholinesterase inhibitors.43 In addition to enzyme inhibition, these phenolic compounds exhibit strong antioxidant properties, which may indirectly support neuronal function. By scavenging reactive oxygen and nitrogen species (ROS and RNS), they can reduce oxidative stress—a key factor implicated in neurodegeneration and synaptic dysfunction.44 Furthermore, certain low-molecular-weight phenolics, including chlorogenic acid and urolithin metabolites derived from ellagic acid, have been reported to cross the blood–brain barrier and exert protective effects on neuronal membranes and mitochondrial function.45, 46 Experimental studies have also demonstrated that pomegranate-derived extracts can modulate multiple neurobiological pathways in vivo, including reduction of amyloid-β deposition, suppression of pro-inflammatory cytokines, and enhancement of endogenous antioxidant defenses such as superoxide dismutase activity.47 These multi-target effects are often associated with activation of cellular antioxidant pathways, including the Nrf2–HO-1 axis, and improved neurotrophic signaling, which together contribute to neuronal survival and synaptic plasticity.48 In contrast, CPDS exhibited comparatively lower inhibitory activity, which is consistent with previous reports describing date seed extracts as moderate sources of phenolic antioxidants. Although date seeds contain bioactive compounds such as catechins, epicatechins, and phenolic acids, their overall phytochemical diversity and concentration appear to be lower than those found in pomegranate peel.49, 50 This difference may limit their ability to effectively interact with cholinesterase enzymes or modulate neurodegenerative pathways. Overall, the results of this study are in agreement with existing literature indicating that plant-derived polyphenols can contribute to cholinesterase inhibition and oxidative stress reduction. However, the magnitude of inhibition observed here remains modest, highlighting the importance of cautious interpretation. The neuroprotective potential suggested by these findings is based solely on in vitro assays and should not be directly extrapolated to therapeutic or clinical applications without further in vivo validation.51 Anti-arthritic activity The results demonstrated that pomegranate peel powder (PPP) exhibited significantly higher inhibition of protein denaturation and proteolytic activity compared to coarse powdered date seeds (CPDS) (p < 0.01), indicating a stronger capacity to protect protein structure under inflammatory-like conditions. These in vitro assays are commonly used as preliminary indicators of anti-inflammatory potential, particularly in relation to protein stability and enzyme-mediated degradation Protein denaturation and increased proteolytic activity are key features associated with inflammatory processes and tissue degradation. In conditions such as osteoarthritis, matrix metalloproteinases (MMPs) play a central role in the breakdown of cartilage and extracellular matrix components. Elevated levels of MMPs, including MMP-1 and MMP-13, have been correlated with increased tissue damage and oxidative stress in clinical studies.52, 53 Although the present study does not directly assess these enzymes, the observed inhibition of protein denaturation and protease activity may reflect a general capacity of the extracts to interfere with processes associated with protein degradation. The higher activity of PPP may be attributed to its richer content of polyphenolic compounds such as punicalagins and ellagic acid, which have been reported to modulate inflammatory signaling pathways, including NF-κB and MAPK, and reduce the production of pro-inflammatory mediators such as TNF-α, IL-1β, and IL-6.54 These mechanisms are often linked to the antioxidant properties of polyphenols, which can reduce oxidative stress and indirectly influence inflammation-related pathways. However, it is important to emphasize that the present findings are based on in vitro assays and do not represent direct evidence of anti-arthritic or therapeutic effects in vivo. The observed activities should therefore be interpreted as indicative of potential bioactivity rather than confirmed physiological or clinical outcomes.55, 56 In comparison, CPDS showed moderate inhibitory effects, which may be related to its lower phenolic content and less diverse phytochemical composition. Although date seeds contain bioactive compounds with reported antioxidant and mild anti-inflammatory properties, their overall efficacy in the present assays was lower than that of PPP, which is consistent with previous reports.57, 58 Overall, the results suggest that PPP possesses stronger in vitro activity related to protein stabilization and inhibition of proteolytic processes compared to CPDS. These findings support its potential as a source of bioactive compounds; however, further studies, including detailed phytochemical characterization and in vivo investigations, are required to validate these effects and clarify their biological relevance. Overall biological relevance The present study demonstrated that pomegranate peel powder (PPP) consistently exhibited higher in vitro biological activity compared to coarse powdered date seeds (CPDS) across antioxidant, cytoprotective, enzyme inhibitory, and anti-arthritic assays. This pattern suggests that the observed effects are not assay-specific, but rather reflect a broader bioactive profile of PPP. The multi-assay performance of PPP may be attributed to the combined action of its phytochemical constituents, particularly polyphenols, flavonoids, and tannins, which are known to act through multiple mechanisms. These include free radical scavenging, metal ion chelation, stabilization of cellular membranes, and modulation of enzyme activity. Such mechanisms are closely related to oxidative stress regulation, which is a common underlying factor across the different biological models evaluated in this study. The consistency of lower IC50 values observed for PPP across different assays further supports its relatively higher in vitro potency. This multi-target activity has been reported in previous studies on polyphenol-rich plant materials, where biological effects are often the result of synergistic interactions rather than a single active compound. However, it is important to note that no phytochemical profiling was conducted in the present study, and therefore these interpretations remain supported by literature rather than direct analytical confirmation. Overall, the findings indicate that PPP represents a promising agro-industrial byproduct with notable in vitro biological activity. Nevertheless, these results should be interpreted with caution, as they are limited to controlled laboratory conditions. Further studies involving detailed phytochemical characterization, bioavailability assessment, and in vivo validation are necessary to confirm the biological relevance of these effects. Clinical nutrition implications The biological activities observed in this study highlight the potential of PPP as a source of natural bioactive compounds that may contribute to oxidative stress modulation. Diets rich in polyphenols have been associated with improved redox balance and reduced inflammation in previous nutritional studies. However, it is important to emphasize that the current findings are based solely on in vitro assays. Therefore, no direct conclusions can be drawn regarding clinical efficacy, therapeutic applications, or disease prevention. Any potential nutritional or health-related benefits of PPP require further validation through in vivo studies and human clinical trials. Conclusion In conclusion, the present study demonstrates that pomegranate peel powder (PPP) exhibits stronger in vitro antioxidant, cytoprotective, acetylcholinesterase inhibitory, and anti-arthritic activities compared to coarse powdered date seeds (CPDS). These effects are likely associated with the higher abundance and diversity of polyphenolic compounds in PPP, including ellagitannins, flavonoids, and phenolic acids, which act through mechanisms such as radical scavenging, metal chelation, membrane stabilization, and enzyme inhibition. This work provides a comparative baseline for the valorization of agro-industrial byproducts as sources of bioactive compounds. However, the findings are limited to in vitro experimental conditions. Further studies involving phytochemical profiling, mechanistic investigations, and in vivo validation are required to confirm these observations. Data availability statement The datasets generated and analyzed during the current study are included in this published article. Further inquiries can be directed to the corresponding author. Ethical statement This study did not involve human participants or animal experiments. Therefore, ethical approval and informed consent were not required. CRediT authorship contribution statement Madyha H. Mahmoud: Project administration, Resources, Software, Supervision. Abdulrahman A. Alsayegh: Writing – original draft, Conceptualization. Nahla Kambal: Investigation, Formal analysis. Asrar Alsaeedi: Resources, Methodology. Boshra M. Mozaffar: Writing – review & editing. Eman Merghani A. Mohammed: Writing – review & editing. Ashwag H. Alwadani: Validation, Data curation. Halah Abdulrahman Hafiz: . Funding This research received no external funding Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Contributor Information Madyha H. Mahmoud, Email: mhmohmoud@jazanu.edu.sa. Abdulrahman A. Alsayegh, Email: aalsayegh@jazanu.edu.sa. Nahla Kambal, Email: nhmohammed@jazanu.edu.sa. Asrar Alsaeedi, Email: aalsaeedi@jazanu.edu.sa. Boshra M. Mozaffar, Email: Bmozaffar@jazanu.edu.sa. Ashwag H. Alwadani, Email: Ashwagalwadani@jazanu.edu.sa. Halah Abdulrahman Hafiz, Email: hahafiz@uqu.edu.sa. References